VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
56 hedge funds and large institutions have $24.2M invested in Viracta Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less capital invested
Capital invested by funds: $40.4M → $24.2M (-$16.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
56
Holding in Top 10
–
Calls
$188K
Puts
$83K
Top Buyers
| 1 | +$229K | |
| 2 | +$182K | |
| 3 | +$173K | |
| 4 |
FSA
Franklin Street Advisors
Chapel Hill,
North Carolina
|
+$54K |
| 5 |
Renaissance Technologies
New York
|
+$38K |
Top Sellers
| 1 | -$523K | |
| 2 | -$44K | |
| 3 | -$40K | |
| 4 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
-$21.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$21.2K |